Fanchuang Medical Biotechnology Co., Ltd.


Customer Demand Is The Best Source Of Innovation

About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsPharmaceutical Intermediates

Rizatriptan Pharmaceutical Intermediates CAS NO 144034-80-0 Rizatriptan Benzoate

Great Service Great Quality.

—— Carl Balfou

I appreciate you because you are so friendly and helpful. You really are a real pleasure to work with so polite and enjoyable to work with.

—— Jeff Rader

You are the sweetest, most caring service possible.

—— Luis Acosta

I'm Online Chat Now

Rizatriptan Pharmaceutical Intermediates CAS NO 144034-80-0 Rizatriptan Benzoate

Large Image :  Rizatriptan Pharmaceutical Intermediates CAS NO 144034-80-0 Rizatriptan Benzoate

Product Details:

Place of Origin: China
Brand Name: R&M
Certification: ISO 9001, USP, GMP
Model Number: 01

Payment & Shipping Terms:

Minimum Order Quantity: 1g
Price: negotiation
Packaging Details: vaccum packing of aluminum foil bag
Detailed Product Description
Pro. Name: Rizatriptan Purity: 99%
Cas: 144034-80-0 Residue On Ignition: ≤0.2%
Molecular Formula: C22H25N5O2 Appreance: White To Off-white Crystalline Powder
High Light:

active pharmaceutical ingredients


bulk pharmaceutical chemicals

Rizatriptan Pharmaceutical Intermediates CAS NO 144034-80-0 Rizatriptan Benzoate




Clinical data
Trade names Maxalt
AHFS/ Monograph
MedlinePlus a601109
  • B1 (Au), C (U.S.)

Routes of
ATC code
  • N02CC04 (WHO)

Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability 45%
Protein binding 14%
Metabolism by monoamine oxidase
Eliminationhalf-life 2–3 hours
Excretion 82% urine; 12% faeces
IUPAC name[hide]
  • N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
CAS Number
  • 145202-66-0 [Yes]

PubChem CID
  • 5078

  • 51

  • DB00953 [Yes]

  • 4900 [Yes]

  • WR978S7QHH

  • D00675 [No]

  • CHEBI:48273 [Yes]

  • CHEMBL905 [Yes]

ECHA InfoCard 100.119.030 [Edit this at Wikidata]
Chemical and physical data
Formula C15H19N5
Molar mass 269.345 g/mol
3D model (JSmol)
  • Interactive image

  • n1cncn1Cc2cc3c(cc2)ncc3CCN(C)C
  • InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3


Rizatriptan (trade name Maxalt) is a 5-HT1 receptor agonist of the triptan class of drugs developed by Merck & Co. for the treatment of migraine headaches.[1] It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).


Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan.


Rizatriptan is available only by prescription in Australia, Finland, the United States, Canada and New Zealand. Similarly, it is classed as a POM (Prescription Only Medicine) in the United Kingdom,Italy (as Rizaliv), France, Israel (as Rizalt), The Netherlands, Croatia and Spain (as Maxalt). It is classified as OTC (over-the-counter) in Brazil (also as Maxalt).

Contact Details
Fanchuang Medical Biotechnology Co., Ltd.

Contact Person: admin

Tel: +8615731109960

Send your inquiry directly to us Message not be empty!